Finance

Lists
BLTE:NASDAQ
Belite Bio Inc
$162.80
-2.09%
(-3.48) 1D
$162.80
0.00% (0.00)
After hours
Closed: Aug 14, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLTE...
Open
$166.51
High
$167.00
Low
$159.00
Mkt. cap
6.53B
Avg. vol.
176.88K
Volume
228.80K
52-wk high
$200.00
52-wk low
$60.00
EPS
-$2.65
Beta
-1.22
Shares outstanding
39.96M
No. of employees
41
Open
$166.51
High
$167.00
Low
$159.00
Mkt. cap
6.53B
Avg. vol.
176.88K
Volume
228.80K
52-wk high
$200.00
52-wk low
$60.00
EPS
-$2.65
Beta
-1.22
Shares outstanding
39.96M
No. of employees
41
News stories
From web sources and news partners
About Belite Bio Inc
CEO-
Employees41
Founded2016
Headquarters-
SectorPharmaceutical industry
Websitebelitebio.com
Analyst ratings
Based on 6 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current $162.80
$270.00 (+65.85%)
Average
$221.00 (+35.75%)
Lowest
$200.00 (+22.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$200.00
+22.9%
08/14/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
-
-
08/14/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$201.00
+23.5%
08/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$220.00
+35.1%
08/14/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$270.00
+65.8%
08/14/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$214.00
+31.4%
08/14/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
$217.00
+33.3%
03/03/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.31M
14.62M
15.66M
18.21M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.71M
13.45M
17.02M
16.69M
Operating expense
23.02M
28.08M
32.68M
34.91M
Total operating expenses
23.02M
28.08M
32.68M
34.91M
Operating income
-23.02M
-28.08M
-32.68M
-34.91M
Other non operating income
-2.14M
-417.00K
5.75M
6.55M
EBT including unusual items
-21.69M
-25.32M
-26.94M
-28.36M
EBT excluding unusual items
-21.69M
-25.32M
-26.94M
-28.36M
Income tax expense
-
-
-
55.00K
Effective tax rate
-
-
-
-0.19%
Other operating expenses
-
-
-
-
Net income
-21.69M
-25.32M
-26.94M
-28.41M
Net profit margin
-
-
-
-
Earnings per share
-0.65
-0.70
-0.68
-0.70
Interest and investment income
3.47M
3.17M
-
-
Interest expense
-
-2.00K
-
-
Net interest expenses
3.47M
3.17M
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.97M
-28.03M
-32.64M
-34.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps